INS and diabetes mellitus: Careful surveillance of the patient’s glycemia and insulin dosing during the hospitalization led to significant improvement in diabetes control parameters, with HbA1c decreasing gradually to 10.3% in week 8, then 7.5% in week 12 and eventually to 6.7% in week 17.